Bliss GVS Pharma quarterly results and financials

Bliss GVS Pharma (BLISSGVS)₹654.75+4.89%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Sep 2026 quarter (consolidated), Bliss GVS Pharma reported sales of ₹312 Cr, up 28.1% from Sep 2025, and net profit of ₹53.07 Cr, up 82.7% year on year. For the year to Mar 2026, sales were ₹925 Cr and net profit ₹135 Cr.

Sales (Sep 2026): ₹312 Cr
Net profit (Sep 2026): ₹53.07 Cr
Sales (FY Mar 2026): ₹925 Cr
Net profit (FY Mar 2026): ₹135 Cr
EPS (Sep 2026): ₹4.92
Borrowings (Mar 2026): ₹21.98 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Bliss GVS Pharma quarterly results

₹ crore unless stated; each column is a quarter.

Bliss GVS Pharma Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	201	198	184	217	210	198	206	244	218	257	285	312
Expenses	156	169	148	175	180	176	165	200	182	212	208	232
Operating Profit	44.09	28.03	34.05	41.04	30.05	21.03	41.06	43.06	35.06	44.04	76.07	81.08
OPM %	22.1%	14.1%	19.1%	19.1%	14.1%	11.1%	20.1%	18.1%	16.1%	17.1%	27.1%	26.1%
Other Income	5.01	−24.03	4.01	5.01	15.01	12.01	35.05	8.01	16.01	11.01	9.99	8.01
Interest	1.99	1.99	1.99	3.99	0.99	1.99	4.98	2.99	0.99	1.99	0.99	2.99
Depreciation	7.02	7.02	7.02	7.02	8.03	8.03	8.03	8.03	8.02	9.03	10.04	10.03
Profit before tax	40.05	−4.01	30.04	36.08	36.09	23.05	63.13	41.07	41.08	45.05	75.17	75.17
Tax %	27.0%	24.0%	26.0%	28.0%	29.0%	28.9%	30.0%	30.0%	39.0%	17.9%	32.0%	29.0%
Exceptional items	0.00	−20.92	0.00	0.00	0.00	0.00	0.00	0.00	−1.99	0.00	0.00	0.00
Net Profit	29.05	−5.01	22.01	26.04	26.03	17.02	44.07	29.04	25.03	37.02	51.08	53.07
EPS (Rs)	2.65	−0.88	1.98	2.32	2.27	1.48	4.09	2.59	2.21	3.37	4.73	4.92

Bliss GVS Pharma profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Bliss GVS Pharma Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	545	796	812	897	687	576	745	750	769	809	925	1,071
Expenses	389	594	616	736	564	469	626	631	618	680	757	835
Operating Profit	156	203	197	160	123	107	118	117	151	127	168	236
OPM %	29.1%	25.1%	24.1%	18.1%	18.1%	18.1%	16.1%	16.1%	20.1%	16.1%	18.1%	22.1%
Other Income	24.03	11.99	−8.01	35.01	26.01	19.99	−42.04	18.01	0.00	36.04	67.01	45.02
Interest	18.93	19.94	22.94	3.99	7.97	5.98	4.99	9.96	6.98	7.98	11.96	6.96
Depreciation	13.04	20.06	21.08	9.03	13.06	17.06	17.08	19.06	26.08	29.11	33.12	37.12
Profit before tax	148	175	145	182	129	104	54.07	106	117	126	190	236
Tax %	31.9%	36.0%	39.0%	30.0%	26.0%	29.0%	57.0%	27.9%	30.0%	27.9%	28.9%	—
Exceptional items	0.00	0.00	−17.94	−1.99	−8.97	0.00	−19.94	0.00	−19.92	0.00	−2.99	−1.99
Net Profit	100	113	89.09	127	95.08	74.11	23.03	77.08	82.08	90.13	135	166
EPS (Rs)	8.01	7.97	5.71	12.01	9.44	6.65	1.46	6.81	7.22	8.02	12.24	15.23
Dividend payout %	6.0%	8.0%	18.0%	8.0%	5.0%	8.0%	34.0%	7.0%	7.0%	6.0%	4.0%	—

Bliss GVS Pharma balance sheet

₹ crore, at each year end.

Bliss GVS Pharma Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.04	10.04	10.03	10.04	10.03	10.03	10.03	10.03	10.04	10.03	11.04	11.04
Reserves	328	403	478	528	637	727	800	810	875	959	1,042	1,185
Borrowings	160	132	225	118	102	126	122	109	102	99.84	87.93	21.98
Other Liabilities	166	218	312	206	157	168	146	181	171	144	162	277
Total Liabilities	663	763	1,025	861	906	1,031	1,079	1,111	1,158	1,213	1,302	1,494
Fixed Assets	234	225	306	143	146	242	234	282	380	370	407	459
CWIP	0.00	8.96	3.99	0.00	46.81	0.00	1.99	21.92	2.99	7.96	20.91	5.98
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.99	7.99	3.99	3.99	5.01
Other Assets	429	528	715	718	713	789	841	805	769	831	872	1,024
Inventories	33.97	38.95	48.94	58.93	76.99	76.97	98.99	124	103	118	126	151
Trade receivables	247	300	254	297	460	547	463	392	384	403	438	516
Cash & equivalents	57.04	78.10	150	89.10	107	103	145	178	103	216	213	167
Total Assets	663	763	1,025	861	906	1,031	1,079	1,111	1,158	1,213	1,302	1,494

Bliss GVS Pharma cash flow

₹ crore, for each year.

Bliss GVS Pharma Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	38.05	113	290	18.03	40.05	47.08	64.16	135	34.06	103	106	139
Cash from investing activity	−28.96	−49.96	−249	47.97	−78.94	−39.98	−44.95	−103	−5.99	−82.92	−74.98	−37.97
Cash from financing activity	−41.86	−39.91	−9.97	−75.73	16.96	−5.98	−20.95	−23.94	−24.91	−20.95	−29.91	−88.71
Net cash flow	−33.90	22.93	29.91	−9.97	−21.93	0.00	−1.99	8.98	2.99	−0.99	0.00	10.97
Capex	27.94	12.99	104	27.96	43.89	58.87	8.99	73.84	93.79	27.95	75.89	56.92
Free cash flow	5.01	101	186	−7.01	2.01	−12.02	55.05	63.11	−59.05	75.09	33.03	84.05
CFO / OP %	44.9%	100.9%	160.0%	29.0%	−8.1%	68.9%	87.0%	142.9%	66.9%	91.0%	111.9%	107.9%

Bliss GVS Pharma ratios

Working-capital days and returns, by year.

Bliss GVS Pharma Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	221	200	115	133	186	289	292	191	186	191	197	203
Inventory days	69	55	50	55	46	64	110	116	94	113	111	129
Days payable	166	154	101	56	48	76	83	87	80	59	64	90
Cash conversion cycle	126	102	67	134	186	279	321	221	202	247	246	244
Working capital days	104	83	−11	134	153	231	263	178	191	206	197	213
ROCE %	23.0%	31.0%	29.1%	27.0%	26.0%	18.0%	12.0%	14.0%	12.0%	14.1%	12.0%	17.0%

Bliss GVS Pharma: frequently asked questions

What are the latest quarterly results of Bliss GVS Pharma?

For the Sep 2026 quarter, Bliss GVS Pharma reported sales of ₹312 Cr, up 28.1% year on year and net profit of ₹53.07 Cr, up 82.7% year on year. The operating margin was 26.1%.

What is the annual revenue of Bliss GVS Pharma?

Bliss GVS Pharma's sales for the year to Mar 2026 were ₹925 Cr; over the last twelve months they were ₹1,071 Cr.

What is the net profit of Bliss GVS Pharma?

Net profit for the year to Mar 2026 was ₹135 Cr, and ₹166 Cr over the last twelve months. Earnings per share over the same trailing period were ₹15.23.

How much debt does Bliss GVS Pharma have?

Bliss GVS Pharma reported borrowings of ₹21.98 Cr at Mar 2026, against cash and equivalents of ₹167 Cr.

What is the free cash flow of Bliss GVS Pharma?

Cash from operations was ₹139 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹84.05 Cr.

Loading…